Jaguar Health, Inc. has entered into privately negotiated exchange agreements with Streeterville Capital, LLC to settle outstanding debt. The company issued a total of 730,000 common shares to reduce its debt obligations by approximately $6.73 million, which includes the full cancellation of a 2025 promissory note.
Key Details
- 2025 Note Cancellation: The company fully paid off and cancelled a secured promissory note from 2025 by issuing 547,898 common shares in exchange for a $5,049,909 reduction in the outstanding balance.
- 2021 Note Reduction: Jaguar Health also reduced the outstanding balance of a 2021 secured promissory note by $1,678,320 in exchange for issuing 182,091 common shares.
- Effective Date: The exchange agreements were entered into on September 23, 2026.